Equities

Beijing Wandong Medical Technology Co Ltd

600055:SHH

Beijing Wandong Medical Technology Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)12.02
  • Today's Change-5.07 / -29.67%
  • Shares traded2.09m
  • 1 Year change-32.51%
  • Beta0.8790
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Beijing Wandong Medical Technology Co Ltd grew revenues 10.30% from 1.12bn to 1.24bn while net income improved 7.51% from 175.37m to 188.54m.
Gross margin38.83%
Net profit margin13.22%
Operating margin14.69%
Return on assets3.50%
Return on equity3.92%
Return on investment3.91%
More ▼

Cash flow in CNYView more

In 2023, Beijing Wandong Medical Technology Co Ltd increased its cash reserves by 5.66%, or 183.06m. The company earned 211.14m from its operations for a Cash Flow Margin of 17.07%. In addition the company generated 59.97m cash from investing, though they paid out 86.78m more in financing than they received.
Cash flow per share--
Price/Cash flow per share--
Book value per share6.74
Tangible book value per share6.69
More ▼

Balance sheet in CNYView more

Beijing Wandong Medical Technology Co Ltd has a strong Balance Sheet and has consistently grown its cash reserves over the last four years to total 3.41bn.
Current ratio10.13
Quick ratio9.48
Total debt/total equity0.0187
Total debt/total capital0.0179
More ▼

Growth rates in CNY

Year on year, growth in dividends per share increased 8.33% while earnings per share excluding extraordinary items fell by -0.68%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)0.66%
Div growth rate (5 year)5.39%
Payout ratio (TTM)45.83%
EPS growth(5 years)-1.11
EPS (TTM) vs
TTM 1 year ago
-6.31
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.